Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Vaccines
|
May 27, 2023
Return on Investment (ROI) of Three Vaccination Programmes in Italy: HPV at 12 Years, Herpes Zoster in Adults, and Influenza in the Elderly
Marco Barbieri, Sara Boccalini
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2008
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies
Marco Barbieri, Neil Hawkins, Mark Sculpher
Physical Review Letters
|
March 1, 2026
Private Remote Phase Estimation over a Lossy Quantum Channel
Farzad Kianvash, Marco Barbieri, Matteo Rosati
Pharmacoeconomics
|
June 18, 2005
The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK
Marco Barbieri, John B Wong, Michael Drummond
Optics Letters
|
October 1, 2024
SPIDERweb: a neural network approach to spectral phase interferometry
Ilaria Gianani, Ian A Walmsley, Marco Barbieri
Journal of Magnetic Resonance Imaging : JMRI
|
October 28, 2024
Improving Accuracy and Reproducibility of Cartilage T<sub>2</sub> Mapping in the OAI Dataset Through Extended Phase Graph Modeling
Marco Barbieri, Anthony A Gatti, Feliks Kogan
NMR in Biomedicine
|
May 9, 2026
Tension-Dependent Variability and Repeatability of Achilles Tendon UTE-T<sub>2</sub>* Mapping Using Mono- and Bi-Exponential Models
Ananya Goyal, Marco Barbieri, Valentina Mazzoli, et al.
Journal of Medical Economics
|
December 21, 2019
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy
Stefano Capri, A Migliore, F Loconsole, et al.
Journal of Medical Economics
|
December 21, 2019
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting
Marco Barbieri, F Loconsole, A Migliore, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
The lag between effectiveness and cost-effectiveness evidence of new drugs. Implications for decision-making in health care
Boyka Stoykova, Michael Drummond, Marco Barbieri, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Vaccines
|
May 27, 2023
Return on Investment (ROI) of Three Vaccination Programmes in Italy: HPV at 12 Years, Herpes Zoster in Adults, and Influenza in the Elderly
Marco Barbieri, Sara Boccalini
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2008
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies
Marco Barbieri, Neil Hawkins, Mark Sculpher
Physical Review Letters
|
March 1, 2026
Private Remote Phase Estimation over a Lossy Quantum Channel
Farzad Kianvash, Marco Barbieri, Matteo Rosati
Pharmacoeconomics
|
June 18, 2005
The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK
Marco Barbieri, John B Wong, Michael Drummond
Optics Letters
|
October 1, 2024
SPIDERweb: a neural network approach to spectral phase interferometry
Ilaria Gianani, Ian A Walmsley, Marco Barbieri
Journal of Magnetic Resonance Imaging : JMRI
|
October 28, 2024
Improving Accuracy and Reproducibility of Cartilage T<sub>2</sub> Mapping in the OAI Dataset Through Extended Phase Graph Modeling
Marco Barbieri, Anthony A Gatti, Feliks Kogan
NMR in Biomedicine
|
May 9, 2026
Tension-Dependent Variability and Repeatability of Achilles Tendon UTE-T<sub>2</sub>* Mapping Using Mono- and Bi-Exponential Models
Ananya Goyal, Marco Barbieri, Valentina Mazzoli, et al.
Journal of Medical Economics
|
December 21, 2019
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy
Stefano Capri, A Migliore, F Loconsole, et al.
Journal of Medical Economics
|
December 21, 2019
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting
Marco Barbieri, F Loconsole, A Migliore, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
The lag between effectiveness and cost-effectiveness evidence of new drugs. Implications for decision-making in health care
Boyka Stoykova, Michael Drummond, Marco Barbieri, et al.
Page
of 10